06 Oct Date October 6, 2020 Categories News Phase 2 human clinical trial shows that metabolic activators reduces recovery time in COVID-19 patients by nearly 30% ScandiBio Therapeutics has completed a Phase II study based on treatment of patients with COVID-19. Patients with mild-to-moderate...
